Lei Chen, MD in St Marys, PA - Obstetrics & Gynecology

Lei Chen, MD is a Obstetrics & Gynecology - Obstetrics physician based in St Marys, Pennsylvania. Lei Chen is licensed to practice in Pennsylvania (license number MD070734L) and his current practice location is 761 Johnsonburg Rd, St Marys, Pennsylvania. He can be reached at his office (for appointments etc.) via phone at (814) 834-6139.

NPI number for Lei Chen is 1578628806 and his current mailing address is 761 Johnsonburg Rd, St Marys, Pennsylvania. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1578628806.

Contact Information

	Lei Chen, MD
	761 Johnsonburg Rd, St Marys, PA 15857-3480
	(814) 834-6139
	(814) 781-3571

Physician's Profile

Full Name	Lei Chen
Gender	Male
Speciality	Obstetrics & Gynecology - Obstetrics
Location	761 Johnsonburg Rd, St Marys, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1578628806
Provider Enumeration Date: 12/27/2006
Last Update Date: 07/09/2007

Medical Identifiers

Medical identifiers for Lei Chen such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1578628806	NPI	-	NPPES
0018010510001	Medicaid	PA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207VX0000X	Obstetrics & Gynecology - Obstetrics	MD070734L (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lei Chen is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Lei Chen, MD 761 Johnsonburg Rd, St Marys, PA 15857-3480 Ph: (814) 834-6139	Lei Chen, MD 761 Johnsonburg Rd, St Marys, PA 15857-3480 Ph: (814) 834-6139

News Archive

When it comes to health care clinics, Wal-Mart falling behind rivals

Five years after Wal-Mart Stores Inc. promised to open thousands of health-care clinics in its sprawling supercenters, it has fallen far behind its industry rivals in what has become a race to provide basic medical care in stores.

AstraZeneca's new precision biologic gets FDA approval to treat severe eosinophilic asthma

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

Intranasal vaccination effectively reduces viral shedding of SARS-CoV-2 in monkeys

A new preprint that appeared on the bioRxiv server reports that intranasal vaccination with the D614G variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus monkeys reduces viral shedding. This is an experiment in non-human primates (NHP), and its extrapolation to humans is unclear as yet.

Long-term use of reverse geometry lenses may induce inflammatory response

Continuous long-term overnight use of reverse geometry lenses results in a significantly increased presence of inflammatory mediators compared with wearing 30-night silicone-hydrogel contact lenses or wearing no lenses, show study results.

FDA grants Orphan Drug Designation to ADXS-HPV for treatment of HPV-associated anal cancer

Advaxis, Inc., (OTCQB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus (HPV)-associated anal cancer.

Lei Chen, MD - Obstetrics & Gynecology in St Marys, PA